Pharmacokinetics and Safety of iGlarLixi in Healthy Chinese Participants: Results of a Phase 1 Randomized Study
Crossref DOI link: https://doi.org/10.1007/s13300-023-01434-0
Published Online: 2023-06-17
Published Print: 2023-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, Panpan
He, Xuemei
Gao, Xin
Shuai, Mengmeng
Schmider, Wolfgang
Jiang, Alex
Yang, Na
Shi, Aixin
Funding for this research was provided by:
Sanofi
Text and Data Mining valid from 2023-06-17
Version of Record valid from 2023-06-17
Article History
Received: 5 April 2023
Accepted: 8 June 2023
First Online: 17 June 2023